Patents by Inventor William Glover
William Glover has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240228355Abstract: Glass manufacturing apparatus comprise a forming body configured to draw a glass forming ribbon and positioned within an enclosure. Glass manufacturing apparatus comprise a first diffuser comprising a first inlet comprising a first inlet cross-sectional area and a first outlet comprising a first outlet cross-sectional area. The first outlet cross-sectional area is greater than the first inlet cross-sectional area. The first outlet is positioned within the enclosure. Methods of manufacturing a glass ribbon comprise flowing a glass-forming ribbon. Methods comprise flowing a first gas through the first inlet of a first diffuser at a first average inlet velocity. Methods comprise flowing the first gas from the first diffuser through a first outlet of the first diffuser at a first average outlet velocity. The first average inlet velocity is greater than the first average outer velocity.Type: ApplicationFiled: May 13, 2022Publication date: July 11, 2024Inventors: Amit Bachar, Olus Naili Boratav, Brendan William Glover, Jiandong Meng, Vinay A Patel, Adam Scott Regula, Justin Shane Starkey, Jeremy Walter Turner
-
Patent number: 11421263Abstract: Provided herein are methods of detecting nucleic acids. The nucleic acid of interest may be detected by using Cas endonuclease to degrade substantially all nucleic acid in a sample except for the nucleic acid of interest, leaving the nucleic acid of interest isolated and amenable to detection. In related methods, Cas endonuclease complexes are used to protect the nucleic acid of interest while unprotected nucleic acid is digested, e.g., by exonuclease, after which the isolated nucleic acid of interest is detected.Type: GrantFiled: July 23, 2019Date of Patent: August 23, 2022Assignee: GENETICS RESEARCH, LLCInventors: Anthony P. Shuber, William Glover, Thomas C. Meyers
-
Publication number: 20220064720Abstract: The invention provides methods of isolating a target nucleic acid in a sample. A primer is hybridized to the target. A polymerase and modified nucleotide resistant to nuclease degradation are used to extend the primer to create a modified polynucleotide. The sample is exposed to a nuclease, thereby isolating the modified polynucleotide. Optionally, the target nucleic acid may be further protected by binding a protein in a sequence specific manner to one end of the target nucleic acid to create a protected target nucleic acid resistant to nuclease degradation. Thus, after exposing the sample to a nuclease, the modified polynucleotide and protected target nucleic acid are isolated.Type: ApplicationFiled: October 11, 2021Publication date: March 3, 2022Inventor: William Glover
-
Patent number: 11224850Abstract: The invention provided methods and devices for performing sequential, regulated multiplex reactions in a single tube without the addition or removal of contents from the tube.Type: GrantFiled: February 20, 2020Date of Patent: January 18, 2022Assignee: GENETICS RESEARCH, LLCInventors: Anthony P. Shuber, William Glover
-
Patent number: 11142788Abstract: The invention provides methods of isolating a target nucleic acid in a sample. A primer is hybridized to the target. A polymerase and modified nucleotide resistant to nuclease degradation are used to extend the primer to create a modified polynucleotide. The sample is exposed to a nuclease, thereby isolating the modified polynucleotide. Optionally, the target nucleic acid may be further protected by binding a protein in a sequence specific manner to one end of the target nucleic acid to create a protected target nucleic acid resistant to nuclease degradation. Thus, after exposing the sample to a nuclease, the modified polynucleotide and protected target nucleic acid are isolated.Type: GrantFiled: June 13, 2018Date of Patent: October 12, 2021Assignee: GENETICS RESEARCH, LLCInventor: William Glover
-
Patent number: 10947599Abstract: The invention provides methods for determining the mutation burden of a tumor by assaying tumor DNA that is representative of genetic loci that are themselves representative of genetics of the tumor. The assayed tumor DNA may be itself agnostic as to loci, so long as it is representative of loci that are representative of tumor mutation burden. The invention provides for assays in which the tumor DNA being sequenced or tested can be something other than, and possibly less than, a full panel of oncogenes that is expected to stand for a tumor's mutational load.Type: GrantFiled: January 23, 2018Date of Patent: March 16, 2021Assignee: GENETICS RESEARCH, LLCInventors: Anthony P. Shuber, William Glover
-
Publication number: 20210032149Abstract: A glass manufacturing apparatus includes an enclosure including an interior area and a vessel positioned at least partially within the interior area of the enclosure. The vessel includes a trough and a forming wedge including a pair of downwardly inclined surfaces that converge at a root of the vessel. A draw plane extends from the root of the vessel through an opening of the enclosure in a draw direction. The apparatus includes a thermal shield moveable along an adjustment direction extending perpendicular to the draw plane. The thermal shield includes a non-metallic outer shell and a thermal insulating core. Additionally, methods of manufacturing a glass ribbon with the glass manufacturing apparatus are provided.Type: ApplicationFiled: November 28, 2018Publication date: February 4, 2021Inventors: David Scott Franzen, Brendan William Glover, Bulent Kocatulum, William Brashear Mattingly, III
-
Publication number: 20200261881Abstract: The invention provided methods and devices for performing sequential, regulated multiplex reactions in a single tube without the addition or removal of contents from the tube.Type: ApplicationFiled: February 20, 2020Publication date: August 20, 2020Inventors: Anthony P. Shuber, William Glover
-
Publication number: 20200103399Abstract: The invention provides methods for detecting small mutations and structural alterations in DNA by using binding proteins to protect those features while digesting unprotected DNA in a sample. To detect small mutations, a protein that binds exclusively to the mutation of interest, and not to wild-type, is used. For structural alterations, binding proteins are used that flank a breakpoint of the alteration. After digestion of unbound, unprotected nucleic acid in the sample, the mutation- or breakpoint-containing segment remains as an isolated DNA fragment. The sample is then assayed to detect any fragment of DNA and the detection of the fragment indicates the presence of the mutation or breakpoint in the subject.Type: ApplicationFiled: December 3, 2019Publication date: April 2, 2020Inventors: Anthony P. Shuber, William Glover
-
Patent number: 10527608Abstract: The invention provides methods for detecting small mutations and structural alterations in DNA by using binding proteins to protect those features while digesting unprotected DNA in a sample. To detect small mutations, a protein that binds exclusively to the mutation of interest, and not to wild-type, is used. For structural alterations, binding proteins are used that flank a breakpoint of the alteration. After digestion of unbound, unprotected nucleic acid in the sample, the mutation- or breakpoint-containing segment remains as an isolated DNA fragment. The sample is then assayed to detect any fragment of DNA and the detection of the fragment indicates the presence of the mutation or breakpoint in the subject.Type: GrantFiled: January 23, 2018Date of Patent: January 7, 2020Assignee: GENETICS RESEARCH, LLCInventors: Anthony P. Shuber, William Glover
-
Publication number: 20190345539Abstract: Provided herein are methods of detecting nucleic acids. The nucleic acid of interest may be detected by using Cas endonuclease to degrade substantially all nucleic acid in a sample except for the nucleic acid of interest, leaving the nucleic acid of interest isolated and amenable to detection. In related methods, Cas endonuclease complexes are used to protect the nucleic acid of interest while unprotected nucleic acid is digested, e.g., by exonuclease, after which the isolated nucleic acid of interest is detected.Type: ApplicationFiled: July 23, 2019Publication date: November 14, 2019Inventors: Anthony P. Shuber, William Glover, Thomas C. Meyers
-
Patent number: 10370700Abstract: Provided herein are methods of detecting nucleic acids. The nucleic acid of interest may be detected by using Cas endonuclease to degrade substantially all nucleic acid in a sample except for the nucleic acid of interest, leaving the nucleic acid of interest isolated and amenable to detection. In related methods, Cas endonuclease complexes are used to protect the nucleic acid of interest while unprotected nucleic acid is digested, e.g., by exonuclease, after which the isolated nucleic acid of interest is detected.Type: GrantFiled: September 17, 2018Date of Patent: August 6, 2019Assignee: GENETICS RESEARCH, LLCInventors: Anthony P. Shuber, William Glover, Thomas C. Meyers
-
Publication number: 20190024143Abstract: Provided herein are methods of detecting nucleic acids. The nucleic acid of interest may be detected by using Cas endonuclease to degrade substantially all nucleic acid in a sample except for the nucleic acid of interest, leaving the nucleic acid of interest isolated and amenable to detection. In related methods, Cas endonuclease complexes are used to protect the nucleic acid of interest while unprotected nucleic acid is digested, e.g., by exonuclease, after which the isolated nucleic acid of interest is detected.Type: ApplicationFiled: September 17, 2018Publication date: January 24, 2019Inventors: Anthony P. Shuber, William Glover, Thomas C. Meyers
-
Publication number: 20180355436Abstract: The invention provides methods for determining the mutation burden of a tumor by assaying tumor DNA that is representative of genetic loci that are themselves representative of genetics of the tumor. The assayed tumor DNA may be itself agnostic as to loci, so long as it is representative of loci that are representative of tumor mutation burden. The invention provides for assays in which the tumor DNA being sequenced or tested can be something other than, and possibly less than, a full panel of oncogenes that is expected to stand for a tumor's mutational load.Type: ApplicationFiled: January 23, 2018Publication date: December 13, 2018Inventors: Anthony P. Shuber, William Glover
-
Publication number: 20180355406Abstract: The invention provides methods of isolating a target nucleic acid in a sample. A polynucleotide region flanking a target nucleic acid may be modified by polymerase extension using modified nucleotides resistant to nuclease degradation to create a modified polynucleotide. Alternatively, an oligonucleotide including the modified nucleotides may be ligated to those regions to create the modified polynucleotide. The sample is exposed to a nuclease, thereby isolating the modified polynucleotide and the target nucleic acid. In other alternatives, terminal phosphates may be removed from a desired portion of a polynucleotide with a double-stranded break to create a modified polynucleotide that is resistant to nuclease degradation, or an epigenetic-binding moiety may be bound to a polynucleotide sequence within or flanking target nucleic acids to sterically inhibit nuclease degradation of the target nucleic acids.Type: ApplicationFiled: June 13, 2018Publication date: December 13, 2018Inventor: William Glover
-
Publication number: 20180355419Abstract: The invention provides methods of isolating a target nucleic acid in a sample. A primer is hybridized to the target. A polymerase and modified nucleotide resistant to nuclease degradation are used to extend the primer to create a modified polynucleotide. The sample is exposed to a nuclease, thereby isolating the modified polynucleotide. Optionally, the target nucleic acid may be further protected by binding a protein in a sequence specific manner to one end of the target nucleic acid to create a protected target nucleic acid resistant to nuclease degradation. Thus, after exposing the sample to a nuclease, the modified polynucleotide and protected target nucleic acid are isolated.Type: ApplicationFiled: June 13, 2018Publication date: December 13, 2018Inventor: William Glover
-
Publication number: 20180356410Abstract: The invention provides methods for detecting small mutations and structural alterations in DNA by using binding proteins to protect those features while digesting unprotected DNA in a sample. To detect small mutations, a protein that binds exclusively to the mutation of interest, and not to wild-type, is used. For structural alterations, binding proteins are used that flank a breakpoint of the alteration. After digestion of unbound, unprotected nucleic acid in the sample, the mutation- or breakpoint-containing segment remains as an isolated DNA fragment. The sample is then assayed to detect any fragment of DNA and the detection of the fragment indicates the presence of the mutation or breakpoint in the subject.Type: ApplicationFiled: January 23, 2018Publication date: December 13, 2018Inventors: Anthony P. Shuber, William Glover
-
Publication number: 20180355380Abstract: Methods and kits are provided that are useful as quality controls for gene editing tools. When a gene editing process is proposed for some subject nucleic acid, the gene editing process may be performed on a representative sampleāa sample that represents the subject nucleic acid. Off-target effects may be measured and shown for the representative sample to show a prospective rate of off-target activity were the gene editing process to be performed on the subject nucleic acid.Type: ApplicationFiled: January 23, 2018Publication date: December 13, 2018Inventors: Anthony P. Shuber, William Glover
-
Patent number: 10081829Abstract: Provided herein are methods of detecting nucleic acids. The nucleic acid of interest may be detected by using Cas endonuclease to degrade substantially all nucleic acid in a sample except for the nucleic acid of interest, leaving the nucleic acid of interest isolated and amenable to detection. In related methods, Cas endonuclease complexes are used to protect the nucleic acid of interest while unprotected nucleic acid is digested, e.g., by exonuclease, after which the isolated nucleic acid of interest is detected.Type: GrantFiled: January 23, 2018Date of Patent: September 25, 2018Assignee: GENETICS RESEARCH, LLCInventors: Anthony P. Shuber, William Glover, Thomas C. Meyers
-
Patent number: 9643874Abstract: An apparatus and methods for making a glass ribbon includes a forming wedge with a pair of inclined forming surface portions converging along a downstream direction to form a root. The apparatus further includes an edge director intersecting with at least one of the pair of downwardly inclined forming surface portions, and a replaceable heating cartridge configured to direct heat to the edge director and thermally shield the edge director from heat loss. A replaceable heating cartridge is also provided for directing heat to the edge director and thermally shielding the edge director from heat loss.Type: GrantFiled: July 6, 2016Date of Patent: May 9, 2017Assignee: Corning IncorporatedInventors: Ren Hua Chung, Ahdi El-Kahlout, David Scott Franzen, Brendan William Glover, Paul Richard Grzesik, Bulent Kocatulum, Gaozhu Peng, Michael John Stephenson